INVESTORS MEDIA CAREERS PARTNERS SUPPLIERS French version HOME OUR GROUP R&D INNOVATION OUR PRODUCTS OUR RESPONSIBILITY Our products Bring new hope to patients through adapted therapeutic solutions You are here : Home > Our Products > Multiple sclerosis Cut Share To print OUR PRODUCTS DIABETES ONCOLOGY HUMAN VACCINES RARE DISEASES MULTIPLE SCLEROSIS OTHERS PRODUCTS GENERAL PUBLIC HEALTH GENERICS ANIMAL HEALTH MANUFACTURING / DISTRIBUTION THE CHALLENGE OF MULTIPLE SCLEROSIS Frequent and yet poorly understood, multiple sclerosis (MS) is an inflammatory disease of the central nervous system (brain and spinal cord), considered an autoimmune pathology. Chronic and evolving in relapses, it can cause very variable symptoms from one relapse to another and from one person to another. This disease occurs most often between the ages of 20 to 40 and is 2 to 3 times more common in women (1). Knowledge of MS has grown considerably and therapeutic advances have made it possible to improve the management of a growing number of patients. Yet patients with multiple sclerosis still have high hopes for research, with the hope that new therapies will change the course of their disease. Aubagio® (teriflunomide), oral immunomodulator (2) Lemtrada® (alemtuzumab), monoclonal antibody (2) For more information on our products for multiple sclerosis: www.genzyme.com / Our products www.genzyme.fr N. Danziger. Neurology. Med-Line Editions, 2011, p.107 For more information, refer to the Summaries of Product Characteristics available locally . www.genzyme.com © Sanofi 2004-2014 - Tous droits réservés - Mise à jour : 05 septembre 2014 SANOFI DANS LE MONDE Sélectionner un pays... Afrique du Sud Algérie Allemagne Arabie saoudite Argentine Australie Autriche Azerbaïdjan Bahreïn Bangladesh Belgique Brésil Bulgarie Cameroun Canada Chili Chine Corée du Sud Danemark Egypte Emirats arabes unis Equateur Espagne Estonie Etats-Unis Finlande France Géorgie Grèce Guatémala Hong-kong Hongrie Inde Indonésie Irlande Israël Italie Japon Jordanie Kazakhstan Koweït Lettonie Liban Lituanie Malaisie Maroc Mexique Norvège Nouvelle-Zélande Oman Ouzbékistan Pakistan Panama Pays-Bas Pérou Philippines Pologne Portugal Qatar République dominicaine République tchèque Royaume-Uni Russie Sénégal Singapour Slovaquie Suède Suisse Syrie Taiwan Thaïlande Tunisie Turquie Ukraine Uruguay Venezuela Viêt Nam Yémen AUTRES SITES WEB Sanofi Pasteur Sanofi Espoir Paediatrics Cepia AUTRES SITES WEB Select a website ... Sanofi Pasteur Sanofi Hope Paediatrics Cepia SANOFI COMPANY Chattem Genzyme Merial Zentiva SANOFI COMPANY Select a company ... Chattem Genzyme Merial Zentiva INFORMATION Contact Sitemap Sanofi subsidiaries websites Help Glossary Publications RSS Legal Notice French version View desktop version